从分子发病机制到新型治疗策略——外周 T 细胞淋巴瘤治疗最新进展综述
From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas.
95.5分
★★★★★
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 24
条件筛选 · 已选 3 项 · 共 24 条展开收起
适应症
皮肤与软组织
其他
靶点
CAR-T 细胞：改善儿童肿瘤结局所缺失的一环？
CAR T cells: the missing piece needed to improve outcomes for children with cancer?
76.8分
★★★★☆
站内排序·非疗效
阻断 CD19 CAR-T 细胞上的 CD30 增强其抗 B 细胞白血病/淋巴瘤的功能能力
Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.
67.9分
★★★☆☆
站内排序·非疗效
57.9分
★★★☆☆
站内排序·非疗效
病例报告：双特异性 CD20/CD30 靶向 CAR-T 细胞治疗非霍奇金淋巴瘤
Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma.
52.1分
★★★☆☆
站内排序·非疗效
将 CAR-T 置于 HRS 之前：靶向经典霍奇金淋巴瘤中霍奇金/Reed-Sternberg 细胞的抗 CD30 免疫治疗进展
Put the CAR-T before the HRS: Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma.
47.8分
★★★☆☆
站内排序·非疗效
霍奇金淋巴瘤的免疫治疗：从单克隆抗体到 CAR-T 细胞治疗
Immunotherapy for Hodgkin lymphoma: From monoclonal antibodies to chimeric antigen receptor T-cell therapy.
47.2分
★★★☆☆
站内排序·非疗效
规模化与扩大应用：工程化 T 细胞治疗生产的进展与挑战
Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
46.9分
★★★☆☆
站内排序·非疗效
儿童和青少年癌症患者 CAR-T 细胞药物研发儿科战略论坛：ACCELERATE 与欧洲药品管理局合作、美国食品药品监督管理局参与
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE i
46.9分
★★★☆☆
站内排序·非疗效
有前景的 B 细胞淋巴增殖性疾病免疫治疗模式
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders.
46.9分
★★★☆☆
站内排序·非疗效